Skip to content

Extended Pancreatic Neck Transection Versus Conventional Pancreatic Neck Transection During Laparoscopic Pancreaticoduodenectomy( LPDEXCEPT)

Extended Pancreatic Neck Transection Versus Conventional Pancreatic Neck Transection During Laparoscopic Pancreaticoduodenectomy( LPDEXCEPT): a Multicenter Randomized Controlled Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05808894
Acronym
LPDEXCEPT
Enrollment
154
Registered
2023-04-12
Start date
2023-08-31
Completion date
2026-06-30
Last updated
2023-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic Pancreaticoduodenectomy

Keywords

laparoscopic pancreaticoduodenectomy, pancreatic neck transection level

Brief summary

The investigators conduct the clinical randomized controlled trial to evaluate the superiority of extended pancreatic neck transection during laparoscopic pancreaticoduodenectomy (LPD). The participants in the study group obtain extended pancreatic neck transection during LPD, while participants in the control group conventional pancreatic neck transection. The purposes of this study include: 1.Primary objective: To compare the incidence of clinically relevant pancreatic fistula (grades B-C according International Study Group on Pancreatic Surgery) between the study group and the control group. 2.Secondary objective: To compare the incidence of postoperative morbidity (Clavien-Dindo score ≥3)between the two groups. To compare the location of pancreatic duct and the surgical performance of pancreaticojejunostomy between the two groups.

Interventions

PROCEDUREextended pancreatic neck transection during laparoscopic pancreaticoduodenectomy

Transect the pancreatic neck at ≥5mm and ≤10mm beyond the left side of the portal vein.

Sponsors

The Affiliated Hospital Of Guizhou Medical University
CollaboratorOTHER
Shandong Provincial Hospital
CollaboratorOTHER_GOV
Qilu Hospital of Shandong University
CollaboratorOTHER
Xinrui Zhu,MD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Patients with benign or resectable malignant tumors of the lower common bile duct, Vater ampulla, head or uncinate process of the pancreas. 2. 18 years old \< age \< 80 years old, no gender limit. 3. Patient is expected survival beyond 3 months. 4. No pregnancy or pregnancy plan within 3 months after surgery. 5. Nutrition risk score \<3 according to the Nutritional Risk Screening for Inpatients 2002 (NRS2002) standard score. 6. No contraindication to surgery for anesthetic evaluation. 7. The subjects voluntarily joined the study and signed an informed consent form, with good compliance and cooperation with follow-up.

Exclusion criteria

1. Patients with borderline resectable and unresectable malignancies. 2. Patients undergoing neoadjuvant chemotherapy or radiotherapy. 3. Patients with tumors exceeding the level of the gastroduodenal artery as measured by preoperative radiography. 4. Intraoperative exploration reveals tumor adhesions with portal vein-superior mesenteric vein, requiring revascularization and reconstruction. 5. Operation transfers to open. 6. Operation transfers to other procedure. 7. The main pancreatic duct can not be found intraoperatively, the duct-to-mucosa pancreaticojejunostomy can not be operated.

Design outcomes

Primary

MeasureTime frameDescription
the incidence of clinically relevant pancreatic fistula3 months postoperativelythe incidence of the clinically relevant pancreatic fistula according the International Study Group of Pancreatic Surgery's definition and grading

Secondary

MeasureTime frameDescription
location of the pancreatic duct in the pancreatic transverse sectionintraoperativelyBefore performing the pancreaticojejunostomy, place the pancreatic transverse section in the central position of the lens. Measure the anterior-posterior diameter of the pancreas and the distance of the pancreatic duct from the back of the pancreas. The location of the pancreatic duct in the pancreatic transverse section is equal to the ratio of the distance of the pancreatic duct from the back of the pancreas to the anterior-posterior diameter of the pancreas.
surgical performance of pancreaticojejunostomyintraoperativelythe duration of pancreaticojejunostomy
postoperative morbidity3 months postoperativelypostoperative morbidity (Clavien-Dindo score ≥3)within 3 months postoperatively
postoperative mortality3 months postoperativelymortality within 3 months postoperatively

Countries

China

Contacts

Primary ContactBing Peng
pengbing84@hotmail.com+862862539242
Backup ContactYunqiang Cai
yunqiangcaiwch@163.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026